Leading Imaging CRO Expands its Advanced Echocardiographic Imaging
December 6, 2019 - WorldCare Clinical (WCC), a leading CRO focused on maximizing
the precision and accuracy of imaging assessments, announced its advanced quantitative
cardiac echo images services. For over
25 years WCC has been performing central reviews of cardiovascular clinical
trial data to determine drug/device safety and efficacy. Although echocardiographic imaging is the
most common cardiac imaging modality, its use as a trial endpoint has been
hampered by acquisition and assessment variability.
"WCC's unique, full-service
offering provides end-to-end logistics, from sonographer training to independent
review of advanced echo measurements such as 3-D imaging and myocardial strain,"
stated Aaron Timm CEO of WCC. "In order
to add these capabilities, we have established strategic partnerships with KOL
cardiologists, echo sonographers and echo software vendors."
WorldCare Clinical is a global imaging CRO that employs
scientific expertise, innovative technology, and operational excellence to
maximize the precision and accuracy of a blinded independent central review of
Phase I – IV clinical trial data. The company has worked with thousands of
sites in more than 60 countries. WCC's robust technology platform processes
over 250 million images annually (CT, MRI, X-Ray, Echo, US, PET). Originally
founded in 1992 by the Massachusetts General Hospital (MGH) Department of
Radiology, WorldCare continues to maintain a strategic relationship with the
Harvard Hospital System as well as other leading academic institutions.
For more information on WCC's services, please visit our
website at www.wcclinical.com or